Nanotechnology: Intelligent design to treat complex disease

被引:655
作者
Couvreur, Patrick [1 ]
Vauthier, Christine [1 ]
机构
[1] Univ Paris Sud, CNRS, UMR 8612, Lab Physicochim Pharmacotech & BiopAtmosphere Lab, F-92296 Chatenay Malabry, France
关键词
autoimmune disease; cancer; drug targeting; infections; industrial development; liposome; metabolic disease; nanoparticle; vaccine; nanotechnology;
D O I
10.1007/s11095-006-0284-8
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The purpose of this expert review is to discuss the impact of nanotechnology in the treatment of the major health threats including cancer, infections, metabolic diseases, autoimmune diseases, and inflammations. Indeed, during the past 30 years, the explosive growth of nanotechnology has burst into challenging innovations in pharmacology, the main input being the ability to perform temporal and spatial site-specific delivery. This has led to some marketed compounds through the last decade. Although the introduction of nanotechnology obviously permitted to step over numerous milestones toward the development of the "magic bullet" proposed a century ago by the immunologist Paul Ehrlich, there are, however, unresolved delivery problems to be still addressed. These scientific and technological locks are discussed along this review together with an analysis of the current situation concerning the industrial development.
引用
收藏
页码:1417 / 1450
页数:34
相关论文
共 403 条
[1]  
Aboubakar M, 2000, DRUG DEVELOP RES, V49, P109, DOI 10.1002/(SICI)1098-2299(200002)49:2<109::AID-DDR4>3.0.CO
[2]  
2-#
[3]  
Adler-Moore J.P., 1993, Journal of Liposome Research, V3, P429, DOI DOI 10.3109/08982109309150729
[4]   In-vivo studies on dexamethasone sodium phosphate liposomes [J].
AlMuhammed, J ;
Ozer, AY ;
Ercan, MT ;
Hincal, AA .
JOURNAL OF MICROENCAPSULATION, 1996, 13 (03) :293-305
[5]   Nanomedicines for overcoming biological barriers [J].
Alonso, MJ .
BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (03) :168-172
[6]   JEJUNAL-ABSORPTION, PHARMACOLOGICAL ACTIVITY, AND PHARMACOKINETIC EVALUATION OF INDOMETHACIN-LOADED POLY(D,L-LACTIDE) AND POLY(ISOBUTYL-CYANOACRYLATE) NANOCAPSULES IN RATS [J].
AMMOURY, N ;
FESSI, H ;
DEVISSAGUET, JP ;
DUBRASQUET, M ;
BENITA, S .
PHARMACEUTICAL RESEARCH, 1991, 8 (01) :101-105
[7]   Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form [J].
Anderson, KE ;
Eliot, LA ;
Stevenson, BR ;
Rogers, JA .
PHARMACEUTICAL RESEARCH, 2001, 18 (03) :316-322
[8]   Evil and/or/as the "good": Omnicentrism, intersubjectivity, and value paradox in Tiantai Buddhist thought [J].
Andresen, J .
JOURNAL OF RELIGION, 2002, 82 (01) :148-149
[9]   Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs [J].
Andresen, TL ;
Davidsen, J ;
Begtrup, M ;
Mouritsen, OG ;
Jorgensen, K .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (07) :1694-1703
[10]   Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug release [J].
Andresen, TL ;
Jensen, SS ;
Jorgensen, K .
PROGRESS IN LIPID RESEARCH, 2005, 44 (01) :68-97